VYNE

VYNE Therapeutics Inc. Common Stock

0.57

USD

VYNE Earnings Reports

Positive Surprise Ratio

VYNE beat 20 of 32 last estimates.

63%

Next Report

Date of Next Report

Mar 04, 2026

Estimate for Q4 25 (Revenue/ EPS)

$204.00K

-$0.18

Implied change from Q3 25 (Revenue/ EPS)

+20.71%

+5.88%

Implied change from Q4 24 (Revenue/ EPS)

+142.86%

-35.71%

VYNE Therapeutics Inc. Common Stock earnings per share and revenue

On Nov 06, 2025, VYNE reported earnings of -0.17 USD per share (EPS) for Q3 25, missing the estimate of -0.13 USD, resulting in a -28.21% surprise. Revenue reached 169.00 thousand, compared to an expected 102.00 thousand, with a 65.69% difference. The market reacted with a +4.59% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 5 analysts forecast an EPS of -0.18 USD, with revenue projected to reach 204.00 thousand USD, implying an increase of 5.88% EPS, and increase of 20.71% in Revenue from the last quarter.

FAQ

What were VYNE Therapeutics Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, VYNE Therapeutics Inc. Common Stock reported EPS of -$0.17, missing estimates by -28.21%, and revenue of $169.00K, 65.69% above expectations.

How did the market react to VYNE Therapeutics Inc. Common Stock's Q3 2025 earnings?

The stock price moved up 4.59%, changed from $0.34 before the earnings release to $0.35 the day after.

When is VYNE Therapeutics Inc. Common Stock expected to report next?

The next earning report is scheduled for Mar 04, 2026.

What are the forecasts for VYNE Therapeutics Inc. Common Stock's next earnings report?

Based on 5 analysts, VYNE Therapeutics Inc. Common Stock is expected to report EPS of -$0.18 and revenue of $204.00K for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.